02 Feb 2024 --- Bioproduction company 21st.Bio is granting access to its precision fermentation technology platform to ingredient manufacturers enabling the production of dairy proteins. The new platform, developed in collaboration with Novozymes, represents a step forward for large-scale production for manufacturers in the industry. This move comes on the heels of the company’s successful beta-lactoglobulin production scale-up. Beta-lactoglobulin, a key milk protein, is important for the nutritional and textural properties of dairy products.
